Latest Breaking News On - Acad dermatol - Page 1 : comparemela.com
Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Hea
France
Japan
Hungary
Milan
Lombardia
Italy
Hamburg
Germany
Austria
United-kingdom
United-states
American